DCOY DCOY
Company Profile ↓Company Overview
DCOY (DCOY) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | -96.18% |
| 6 Months: | -48.80% |
| 3 Months: | -28.25% |
| 1 Month: | -40.31% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)39.09 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 96.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 242.55K | 335.52K | 413.60K | 282.83K | 178.58K | 245.50K | 469.05K | 163.07K | 104.98K | 895.78K | 874.95K | 1.13M | 1.24M | 1.38M | 1.27M | 571.39K | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | -8.17M | - | -9.70M | -11.47M | -10.74M | -7.98M | -8.35M | -8.88M | -9.41M | -8.09M | -8.28M | -9.10M | -313.51K | -2.02M | -2.24M | -912.10K | -3.76M | -2.37M | -1.90M | -1.76M | -1.80M | -3.12M | -3.75M | -6.12M | -4.76M | -14.49M | -5.42M | -3.97M | -2.53M | -1.77M | -1.47M | -1.01M | -1.72M | -965.57K | -895.13K | -2.28M |
| Net Income | -1.99M | -3.74M | -6.02M | -7.08M | -8.15M | -7.89M | -9.59M | -11.36M | -10.64M | -7.90M | -8.27M | -8.80M | -9.33M | -8.03M | -381.55K | 111.23K | -307.45K | -2.01M | -1.52M | -903.64K | -2.63M | -2.08M | -1.78M | -1.72M | -1.85M | -3.07M | -3.74M | -6.11M | -4.72M | -14.41M | -5.34M | -3.88M | -2.44M | -1.72M | -1.42M | -972.12K | -1.71M | -957.83K | -873.47K | -2.22M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.13 | -0.10 | -0.06 | -0.07 | -2.09 | -3.30 | -2.20 | -6.41 | -2.23 | -11.45 | -5.21 | -3.27 | -2.37 | -11.38 | -240.07 | -0.45 | -1.81 | -4.18 |
| R&D Expense | 909.12K | 1.97M | 2.80M | 3.19M | 3.45M | 3.31M | 4.39M | 6.09M | 5.67M | 4.23M | 3.91M | 4.08M | 4.74M | 4.26M | 4.68M | 6.17M | 353.61K | 187.76K | 1.71K | 840.14K | 1.14M | 1.64M | 1.44M | 1.80M | 1.74M | 2.10M | 2.02M | 4.44M | 2.92M | 3.79M | 3.73M | 2.35M | 1.04M | 243.00K | 214.45K | 137.23K | 75.53K | 116.38K | 61.83K | 749.81K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1.01M | 1.27M | 1.95M | 3.47M | 5.23M | 1.84M | 0 | - | - | - |
| Operating Income | -8.03M | -29.21M | -39.89M | -34.73M | -1.68M | -8.27M | -7.79M | -12.81M | -31.84M | -12.89M | -5.73M | -12.61M |
| Net Income | -8.01M | -29.14M | -39.49M | -34.43M | -1.67M | -6.94M | -7.35M | -12.77M | -31.61M | -12.54M | -5.58M | -12.52M |
| Diluted EPS | - | - | - | - | - | - | -0.50 | -7.72 | -14.88 | -30.74 | -69.54 | -129.10 |
| R&D Expense | 4.00M | 12.75M | 20.38M | 16.99M | 1.29M | 4.02M | 6.91M | 8.55M | 15.84M | 7.17M | 770.03K | 368.17K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Feb 2014 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 35.61M | 95.07M | 63.21M | 34.99M | 6.61M | 13.89M | 24.93M | 40.83M | 14.65M | 6.59M | 3.02M | 11.06M |
| Total Equity | 0 | -6.54M | 92.19M | 59.32M | -2.90M | -1.27M | 10.58M | 22.16M | 38.72M | 10.38M | 5.29M | 1.51M | 5.89M |
| Cash & Equivalents | - | - | - | - | 19.19M | 3.23M | 3.74M | 11.12M | 29.21M | 12.11M | 5.90M | 2.43M | 10.71M |
| Total Liabilities | - | 1.12M | 2.88M | 3.90M | 5.89M | 7.88M | 3.31M | 2.77M | 2.11M | 4.27M | 1.30M | 1.51M | 5.17M |
| Current Liabilities | - | 1.07M | 2.85M | 3.89M | 5.85M | 1.11M | - | - | - | - | - | 1.51M | 5.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.48M | -20.75M | -32.05M | -27.72M | 4.18M | -11.58M | -10.31M | -10.20M | -17.60M | -12.85M | -4.53M | -4.83M |
| Investing Cash Flow | -76.14K | -27.27M | -12.24M | 24.49M | 0 | 5.61M | -2.60K | 0 | -1.50M | 0 | 0 | 764.74K |
| Financing Cash Flow | 40.41M | 80.84M | 22.10K | 2.63K | 1.44M | 3.58M | 17.69M | 28.30M | 1.99M | 6.64M | 1.06M | 12.34M |
| Capital Expenditure | -76.14K | -265.62K | -559.38K | -113.50K | -0 | -0 | -2.60K | -0 | - | - | - | - |
| Free Cash Flow | -6.56M | -21.01M | -32.61M | -27.84M | 4.18M | -11.58M | -10.31M | -10.20M | - | - | - | - |
| Dividends Paid | - | - | - | - | 0 | 133.59K | 0 | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | -3,946.5% | -2,724.6% | -86.3% | -238.5% | -148.8% | -696.3% | - | - | - | - |
| Net Margin % | - | - | -3,907.6% | -2,701.7% | -85.6% | -200.2% | -140.5% | -693.8% | - | - | - | - |
| ROE % | 122.5% | -31.6% | -66.6% | 1,187.2% | 131.4% | -65.6% | -33.2% | -33.0% | -304.4% | -237.2% | -368.8% | -212.6% |
| ROCE % | -23.2% | -31.7% | -67.2% | -119.1% | -30.6% | - | - | - | - | - | -379.3% | -214.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DCOY
Decoy's antiviral applications span 7 jurisdictions, with 19 pending - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPb3hWMk1PYlJJYzJTZXZXLU1FNXNVWHNmaGs4Z1VlRG9veGtzUVoxVGZMb1VzU1Z6aS1hSU1UU2lUcWdxWWYxOEhqTnJxcjBsdDBHbi03cTF1YmdxLUdUam90cGpGZlk1WDBOekFsN1luUmJROWlnWG5XNjl6dWZqV2VrejI3Qk1Xczcybn…
DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOZ3pBWFZPbmNVbGlNd3FyeFhnUFprVnNWa1d1VXpBS3dUc0pubUtucWd1aFNqY0kzeERLc0liME1tbkhRY2FOR2w1M3ZZUjR5SFhSbE5qNDBQWktFU3J6VExoaTE0dUhscS1iR19JUzFDeXhGd1oyTzlKa3JnSTIwajFtS1BaWEgza0RwVH…
DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxNMzVVMmVVMk53NVFub2MzN1ozVmxURHFCa0pldERiRXZ6SFp4YUhxS05sZkt3ZWxBWndPaXZ5dnlIeFRqRE1oMEZNS3l4SmRRRjk1ZjlzbHVTd0lkeUJQbFVDZGhGVlRPaUg1cGpYOEhMSVczUUlJcjFZWU5zUHR2N0ZGOGdfZzdkRmVTQT…
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - PR Newswire
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPVThYQkxuMmdrVnRzYzBIN3dPMUtmVkRmZFA4U2V5UENXSFhlNEs0akFTVGhrWE5aZGx2OUhlTm5ROU5XeE9DSVpZb0tPVzBOU2xKOVBfWk1fcUhxYWUwSlRkM3UtLWVwdDZZYUR1NTNlNTdBY2dmS3piMVJzTnhhaG4zdUJ6aGN4T1VlbF…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBTT2c5SWFjLVdnd3NfbWdFdUZaSGQtRFh5YWdNbjNfbE9YYWgwY3VUM3pjLUNWQUZTRnQ4NjZQazBSVDRfeFlNZ3JoLXhabzdq?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Decoy Therapeutics Inc. Revenue Breakdown – NASDAQ:DCOY - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBoZFdZYkN4djlOcGZvc2RmSEJib1M2ZEhha05ja3FyY2RVS3B6MVh6Z0lfdTVnYUpCS3YzZTI5QVUtbkRkb19oVGI5aEV1X2FhZXctcEFPVmpqRTFIT2lTdHQ0SWM2Ymx2Zmd3ZS1uSjlFc2VNSDdJ?oc=5" target="_blank">Decoy T…
DCOY — Frequently Asked Questions
What is the current share price of DCOY?
As of 2026-08-05 17:25 PDT, DCOY trades at $4.19 on NASDAQ/NYSE. Its 52-week range is $3.74 to $109.80.
What is the P/E ratio of DCOY?
DCOY trades at a trailing price-to-earnings (P/E) ratio of -0.03.
Is DCOY a good stock to buy?
This page provides a data-driven analysis of DCOY, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.